4 completed. 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 4 |
Follow Viamet: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Efficacy and Safety of Oral VT-1161 in Patients With Onychomycosis of the Toenail VT-1161, Placebo - Onychomycosis | Phase 2 | Completed | Viamet | 259 | 2015-02-17 | 2020-11-04 |
| A Study to Evaluate Oral VT-1161 in the Treatment of Patients With Recurrent Vaginal Candidiasis (Yeast Infection) VT-1161, Placebo - Recurrent Vulvovaginal Candidiasis | Phase 2 | Completed | Viamet | 254 | 2015-02-10 | 2019-10-15 |
| A Study to Evaluate the Efficacy and Safety of Oral VT-1161 in Patients With Moderate - Severe Interdigital Tinea Pedis VT-1161, placebo - Tinea Pedis | Phase 2 | Completed | Viamet | 50 | 2013-08-01 | 2018-08-01 |
| A Study to Evaluate the Efficacy and Safety of Oral VT-1161 in Patients With Acute Vaginal Candidiasis (Yeast Infection) VT-1161, Fluconazole - Candidiasis, Vulvovaginal | Phase 2 | Completed | Viamet | 55 | 2013-08-01 | 2018-08-01 |
Candidiasis, Vulvovaginal (2) · Onychomycosis (1) · Tinea Pedis (1)
VT-1161 (4) · Fluconazole (1)
United States (4)